EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Antisense oligonucleotides targeting IRF4 alleviate psoriasis

Yanxia Yu, Yirui Wang, Weiwei Chen, Chang Zhang, Zhuo Li, Jing Yu, Minhao Wang, Can Song, Sihao Yan, Jiayi Lu, Liangdan Sun

Acta Pharmaceutica Sinica B · 2025-07 · 15 (7) · 3575-3590

DOI: 10.1016/j.apsb.2025.05.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2025-07. Verfasst von Yanxia Yu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, the First Affiliated Hospital of Anhui Medical University, Hefei 230032, China. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Key Technologies Research and Development Program of Anhui Province, Natural Science Foundation of Hebei Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

CD4EP300IL-17AIL-1βIL-23AIRF4PathogenesisPsoriasis

Autor:innen und Institutionen

  • Department of Dermatology, the First Affiliated Hospital of Anhui Medical University, Hefei 230032, China.
  • Key Laboratory of Dermatology (Anhui Medical University), Ministry of Education, Hefei 230032, China.
  • Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Hefei 230032, China.
  • Hebei Key Laboratory of Medical Engineering and Integrated Utilization of Saline Alkali Land, Tangshan 063210, China.
  • Department of Dermatology, North China University of Science and Technology Affiliated Hospital, Tangshan 063000, China.
  • School of Public Health, North China University of Science and Technology, Tangshan 063210, China.

Förderung

  • Key Technologies Research and Development Program of Anhui Province
  • Natural Science Foundation of Hebei Province

Zitieren

APA

Yu, Y., Wang, Y., Chen, W., Zhang, C., Li, Z., Yu, J., Wang, M., Song, C., Yan, S., Lu, J., & Sun, L. (2025). Antisense oligonucleotides targeting IRF4 alleviate psoriasis. Acta Pharmaceutica Sinica B, 15(7), 3575-3590. https://doi.org/10.1016/j.apsb.2025.05.004

Vancouver

Yu Y, Wang Y, Chen W, Zhang C, Li Z, Yu J, et al. Antisense oligonucleotides targeting IRF4 alleviate psoriasis. Acta Pharmaceutica Sinica B. 2025;15(7):3575-3590. doi:10.1016/j.apsb.2025.05.004

BibTeX
@article{Yu2025,
  author = {Yu, Yanxia and Wang, Yirui and Chen, Weiwei and Zhang, Chang and Li, Zhuo and Yu, Jing and Wang, Minhao and Song, Can and Yan, Sihao and Lu, Jiayi and Sun, Liangdan},
  title = {Antisense oligonucleotides targeting IRF4 alleviate psoriasis},
  journal = {Acta Pharmaceutica Sinica B},
  year = {2025},
  volume = {15},
  number = {7},
  pages = {3575--3590},
  doi = {10.1016/j.apsb.2025.05.004}
}
Kostenlos starten →